Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.24.1.1.u2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 77,757 $ 86,411
Restricted cash 3,325 5,650
Inventory, net 31,451 28,776
Prepaid expenses and other current assets 3,422 3,359
Total current assets 115,955 124,196
Restricted cash 502 2,802
Property and equipment, net 10,008 11,625
Operating lease right-of-use assets 9,043 9,612
Other long-term assets 2,355 2,507
Total assets 137,863 150,742
Current liabilities:    
Accounts payable 8,200 8,074
Accrued expenses 11,939 16,020
Deferred revenue 6,569 7,154
Operating lease liabilities, current 1,703 3,489
Other current liabilities 482 306
Total current liabilities 28,893 35,043
Debt, noncurrent 72,533 71,662
Operating lease liabilities, noncurrent 7,610 14,404
Derivative liabilities 11,313 11,511
Total liabilities 120,349 132,620
Commitments and contingencies (Note 6)
Temporary equity, shares issued (in shares) 10,000 10,000
Redeemable convertible preferred stock, $0.0001 par value - 100,000,000 shares authorized at March 31, 2024 and December 31, 2023; 10,000 shares issued and outstanding at March 31, 2024 and December 31, 2023 $ 10,000 $ 10,000
Stockholders’ equity:    
Common stock - $0.0001 par value – 600,000,000 Class A shares authorized at March 31, 2024 and December 31, 2023; 32,477,667 and 32,183,695 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively; 200,000,000 Class B shares authorized at March 31, 2024 and December 31, 2023; 5,704,431 and 5,724,199 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively 4 4
Additional paid-in capital 631,991 629,208
Accumulated deficit (624,481) (621,090)
Total stockholders’ equity 7,514 8,122
Total liabilities, redeemable convertible preferred stock and stockholders’ equity $ 137,863 $ 150,742